Thyroid function after diagnostic (123)I-metaiodobenzylguanidine in children with neuroblastic tumors

BACKGROUND: Metaiodobenzylguanidine (MIBG) labeled with radioisotopes can be used for diagnostics (123)I(−)) and treatment ((131)I(−)) in patients with neuroblastic tumors. Thyroid dysfunction has been reported in 52% of neuroblastoma (NBL) survivors after (131)I-MIBG, despite thyroid protection. Di...

Descripción completa

Detalles Bibliográficos
Autores principales: Clement, Sarah C., Tytgat, Godelieve A. M., van Trotsenburg, A. S. Paul, Kremer, Leontien C. M., van Santen, Hanneke M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132835/
https://www.ncbi.nlm.nih.gov/pubmed/35499668
http://dx.doi.org/10.1007/s12149-022-01743-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132835/
https://www.ncbi.nlm.nih.gov/pubmed/35499668
http://dx.doi.org/10.1007/s12149-022-01743-7

Ejemplares similares